Melanoma

Noninvasive Imaging Technology Distinguishes Between Benign and Malignant Skin Lesions
By Rosemary Frei, MSc
Melanoma, Solid Tumors
September 2014, Vol 5, No 7
Toronto, Ontario—New laser-based imaging technology differentiates malignant melanoma from other cancerous and benign skin lesions, according to a preliminary study presented at the 2014 Canadian Dermatology Association annual conference.
Read Article
Association Between Indoor Tanning and Melanoma Confirmed in New Meta-Analysis
By Rosemary Frei, MSc
Melanoma, Personalized Medicine, Solid Tumors
August 2014, Vol 5, No 6
Toronto, Ontario—Going to more than 10 indoor tanning sessions over a person’s lifetime is associated with a 34% increased risk of developing melanoma, according to a new meta-analysis presented at the 2014 Canadian Dermatology Association annual meeting.
Read Article
Ipilimumab: A New Era in Metastatic Melanoma Management
By Timothy G. Tyler, PharmD, FCSHP
Melanoma, Personalized Medicine
August 2011, Vol 2, No 5
The development of ipilimumab (Yervoy) and its approval by the US Food and Drug Administration (FDA) in March 2011 have opened a new era in the treatment and management of patients with metastatic melanoma.
Read Article

Page 2 of 2

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.

We Value Your Feedback! Tell Us How You Consume Content

Your feedback will help us tailor our content to better meet your needs and preferences.

*First Name
*Last Name
*Email
*What's your favorite format for experiencing our content?